Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.
about
A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosisApplying of hierarchical clustering to analysis of protein patterns in the human cancer-associated liverDifferential proteomic analysis of caveolin-1 KO cells reveals Sh2b3 and Clec12b as novel interaction partners of caveolin-1 and Capns1 as a potential mediator of caveolin-1-induced apoptosis.A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models.Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomicsiTRAQ-Based Quantitative Proteomic Analysis of the Initiation of Head Regeneration in Planarians.Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+ cellular models of breast cancerSalivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer ProgressionGlobal protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenografts.Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
P2860
Q28383207-5A678018-6965-4B02-96E4-A581AA91CE2CQ28541543-72F517DC-F7ED-45FA-BB08-3E8F2057240FQ34194615-51B7AEED-17B4-4794-B98F-4F133D001CD8Q34331673-C7C3A643-FE9B-4ADD-A527-D52186AC9906Q35154283-108D5C06-78D6-410D-8471-4F0EBAC317BCQ35626023-C7408E8E-0EE6-414E-A04F-AC642D93343CQ35679725-DB5BC5CD-8D41-4363-B69B-0E062AD40955Q35834359-4EC6B4F0-CD06-4B9B-BB49-DDFD008B8150Q35909258-9DD731FA-E976-4E1E-B57C-4D596693BF7DQ37141148-D5332DBB-0D22-4F0D-B5D1-5DAA91458DEFQ39108385-1D5B1778-CF1A-429C-ABDF-AF271C4AC392Q47301897-30711054-7C09-46E1-A51F-B9E95A0EEDFC
P2860
Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inferring predominant pathways ...... ed sample proteomic profiling.
@ast
Inferring predominant pathways ...... ed sample proteomic profiling.
@en
type
label
Inferring predominant pathways ...... ed sample proteomic profiling.
@ast
Inferring predominant pathways ...... ed sample proteomic profiling.
@en
prefLabel
Inferring predominant pathways ...... ed sample proteomic profiling.
@ast
Inferring predominant pathways ...... ed sample proteomic profiling.
@en
P2860
P356
P1433
P1476
Inferring predominant pathways ...... ed sample proteomic profiling.
@en
P2093
Vivian Suarez
Yogesh M Kulkarni
P2860
P2888
P356
10.1186/1471-2407-10-291
P407
P577
2010-06-15T00:00:00Z
P5875
P6179
1000468578